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Objectives This study sought to investigate a novel method to calculate the index of microcircula-
tory resistance (IMR) in the presence of signiﬁcant epicardial stenosis without the need for balloon
dilation to measure the coronary wedge pressure (Pw).
ackground The IMR provides a quantitative measure of coronary microvasculature status. How-
ver, in the presence of signiﬁcant epicardial stenosis, IMR calculation requires incorporation of the
oronary fractional ﬂow reserve (FFRcor), which requires balloon dilation within the coronary artery
for Pw measurement.
ethods A method to calculate IMR by estimating FFRcor from myocardial FFR (FFRmyo), which does
not require Pw measurement, was developed from a derivation cohort of 50 patients from a single
institution. This method to calculate IMR was then validated in a cohort of 72 patients from 2 other
different institutions. Physiology measurements were obtained with a pressure-temperature sensor
wire before coronary intervention in both cohorts.
Results From the derivation cohort, a strong linear relationship was found between FFRcor and
FRmyo (FFRcor  1.34  FFRmyo  0.32, r
2  0.87, p  0.001) by regression analysis. With this
equation to estimate FFRcor in the validation cohort, there was no signiﬁcant difference between
IMR calculated from estimated FFRcor and measured FFRcor (21.2  12.9 U vs. 20.4  13.6 U, p 
0.161). There was good correlation (r  0.93, p  0.001) and agreement by Bland-Altman analysis
between calculated and measured IMR.
Conclusions The FFRcor, and, by extension, microcirculatory resistance can be derived without the need
or Pw. This method enables assessment of coronary microcirculatory status before or without balloon
inﬂation, in the presence of epicardial stenosis. (J Am Coll Cardiol Intv 2013;6:53–8) © 2013 by the
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54Recent studies have highlighted the importance of assessing
the coronary microcirculation in various settings (1–6).
However, most of the currently available methods to assess
the coronary microcirculation are dependent on exclusion of
concurrent coronary epicardial disease (1–4).
The index of microcirculatory resistance (IMR) is a
pressure-temperature sensor guidewire-based measurement,
performed during cardiac catheterization, of the minimum
microcirculatory resistance in a target coronary artery terri-
tory (7). It provides a specific quantitative method to assess
the coronary microvasculature in the clinical setting (8–11).
In the absence of significant coronary epicardial disease,
the IMR can be derived by a simplified formula for the
apparent IMR (IMRapp), which is equivalent to the distal
oronary pressure divided by coronary flow. This formula
assumes that coronary flow is equiv-
alent to myocardial flow and that
collateral flow is negligible (7). In
the presence of significant epicardial
stenosis, collateral flow contributes
substantially to myocardial flow,
while coronary flow decreases. Dis-
tal coronary pressure will decrease to
a lesser degree, given that it will be
augmented by the collateral flow.
Therefore, the IMRapp will overes-
timate microcirculatory resistance in
the presence of significant epicardial
stenosis (12–15).
Calculation of the IMR in the
presence of significant epicardial
stenosis is possible but requires
additional measurement of the
coronary wedge pressure (Pw)
during balloon inflation to ac-
count for collateral flow in an
expanded formula for the true
IMR (12–15). This means that
IMR measurement in this setting
equires balloon inflation within the coronary arteries. There-
ore, IMR measurement in patients with epicardial stenosis has
enerally been restricted to only those who are undergoing
ercutaneous coronary intervention (PCI). In this current
tudy, we aimed to develop a method to calculate the IMR
ithout the need for wedge pressure measurement, because
his could enable specific interrogation of the microcirculation
n the presence of significant epicardial disease in the cardiac
atheterization before or without performing PCI.
ethods
Formula derivation. True IMR, in the presence of epicardial
tenosis, can be calculated by the formula IMR  Pa  Tmn 
Abbreviations
and Acronyms
FFRcor  coronary fractional
flow reserve
FFRmyo  myocardial
ractional flow reserve
MR  index of
microcirculatory resistance
IMRapp  apparent index of
microcirculatory resistance
IMRcalc  calculated index
of microcirculatory
resistance
Pa  proximal arterial
ressure
CI  percutaneous
coronary intervention
Pd  distal arterial pressure
w  coronary wedge
ressure
mn  transit time during
hyperemia([Pd  Pw]/[Pa  Pw]), where Pa  mean proximal coronary vressure, Tmn  mean hyperemic transit time, and Pd  mean
distal coronary pressure (16). The terminal part of the formula
([Pd  Pw]/[Pa  Pw]) is also known as the coronary fractional
ow reserve (FFRcor), which refers to the ratio of maximal blood
ow in the target coronary artery to the hypothetical maximal
lood flow in the same territory if there was no stenosis (17). This
s distinct from the FFR commonly used in clinical practice, the
yocardial FFR (FFRmyo Pd/Pa), which represents the ratio of
aximal blood flow in the target myocardium to the hypothetical
aximal blood flow in the same territory as if there was no
tenosis (18,19). We hypothesized that FFRcor is associated with
FRmyo in a mathematically predictable relationship. We sought
to determine the mathematical relationship between FFRcor and
FFRmyo in a derivation cohort. With this relationship to calculate
he FFRcor without Pw measurement in a separate validation
ohort, the accuracy of calculated IMR (IMRcalc) without Pw
measurement was examined.
Study population. The relationship between FFRmyo and
FRcor was investigated in 50 consecutively recruited patients
rom a tertiary referral hospital, who formed the derivation
ohort. The validation cohort comprised 72 patients who
nderwent PCI from 2 separate tertiary institutions. Patients
ndergoing elective PCI for stable angina or unstable angina
ere included in the study for both derivation and validation
ohorts. Patients with recent myocardial infarction or previous
nfarction in the territory of interest were excluded from this
tudy. The study was approved by the human research ethics
eview boards of the respective institutions. Written informed
onsent was obtained from all participants.
Coronary physiology measurements. For both the derivation
nd validation cohorts, coronary physiology measurements
ere performed before PCI as we have previously described
8,13,20). In brief, a 6-F angioplasty guiding catheter without
ide-holes was first used to engage the left main coronary artery.
pressure-temperature sensor guidewire (Certus Pressure Wire,
t. Jude, St. Paul, Minnesota) was used for physiology measure-
ents and PCI. Pressure measurement from the wire was
rst equalized with that of the guiding catheter. The lesion
as crossed, and the pressure sensor was positioned two-
hirds of the way down the artery, at least 3 cm beyond the
esion. Intracoronary nitroglycerin was administered (100 to
00 g). Hyperemia was induced with adenosine infusion
(140 g/kg/min) via the femoral vein. The Pa, Pd, and Tmn
were recorded. Patients then underwent PCI, and Pw was
ecorded during the first balloon inflation.
Statistical analysis. Results are expressed as mean  SD
unless otherwise stated. Linear and nonlinear regression
analyses were used to determine the relationship between 2
variables. To obtain the regression formula of best fit, curves
of increasing complexity starting from a straight line were
tested against one another with the F test. Independent
t tests were used to compare variables between patient
ohorts, and Fisher exact test was used to compare categorical
ariables. Paired t tests were used to compare the different
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55methods to calculate IMR. Pearson’s correlation analyses were
used to evaluate associations between variables, and Bland-
Altman analyses were used to test for agreement. All formal
statistical analyses were performed with SPSS (version 15,
SPSS, Chicago, Illinois). Figures and graphs were generated
with Prism (version 5.01, Graphpad, La Jolla, California). A
2-tailed p value of 0.05 is considered significant.
esults
Population characteristics. A comparison of the clinical
haracteristics between the derivation and validation cohorts
s shown in Table 1. Compared with the derivation cohort,
he validation cohort had higher estimated glomerular
ltration rate, higher FFRmyo, and fewer number of anterior
descending artery lesions. The differences between the
patient groups in the 2 institutions of the validation cohort
are shown in Online Table 1.
Derivation of method to calculate IMR without the wedge
pressure. There was a strong linear relationship between FFRcor
and FFRmyo in the derivation cohort, and FFRcor could be
redicted by the Equation 1.34  FFRmyo  0.32 (r
2  0.87,
 0.001) (Fig. 1). The equation for a straight line was a better
Table 1. Baseline Clinical Characteristics in the Derivation and
Validation Cohorts
Variable
Derivation Cohort
(n  50)
Validation Cohort
(n  72) p Value
Age, mean yrs 62.0 10.2 61.9 11.2 0.945
Male 37 (74) 59 (82) 0.493
Body mass index 28.6 5.4 28.7 4.5 0.915
Comorbidities
Diabetes 10 (20) 20 (28) 0.519
Hypertension 31 (62) 52 (72) 0.423
Dyslipidemia 32 (64) 53 (74) 0.421
Family history 15 (30) 22 (31) 1.000
History of smoking 23 (46) 35 (49) 0.848
eGFR, ml/min/1.73 m2 83.5 18.6 100.5 37.8 0.001
Coronary physiology
measurements
Myocardial fractional ﬂow
reserve
0.57 0.16 0.67 0.18 0.002
IMR, U 23.2 13.8 20.4 13.6 0.282
Coronary wedge pressure,
mm Hg
17.7 9.3 17.8 8.6 0.920
Target territory
Left anterior descending 41 (82) 41 (57)
Left circumﬂex 4 (8) 20 (28) 0.011
Right coronary artery 5 (10) 11 (15)
Indication
Stable angina 35 (70) 68 (94) 0.001
Unstable angina 15 (25) 4 (6)
Values are mean SD or n (%).
eGFR  estimated glomerular filtration rate calculated by the Modification of Diet in RenalDisease formula; IMR index of microcirculatory resistance.t compared with more complex nonlinear equations, including
xponential and second order polynomial equations.
Validation of method to calculate IMR without the wedge
pressure. In the validation cohort, there was no significant
difference between measured and calculated FFRcor (0.56 
0.25 vs. 0.57  0.24, p  0.090). There was also good
orrelation (r  0.96, p  0.001) and agreement between
he 2 variables (Fig. 2).
The IMRcalc was derived with the calculated FFRcor in
the validation cohort. There was no significant difference
between true IMR and IMRcalc (20.4  13.6 U vs. 21.2 
12.9 U, p  0.161) (Fig. 3A). There was good correlation
(r 0.93 p 0.001) and agreement between true IMR and
IMRcalc (Figs. 3B and 3C). Figure 3C also demonstrates
hat IMRcalc deviated from true IMR when FFRmyo was
0.45. The FFRmyo was 0.45 in 76.2% of the whole
ohort, 72.0% of the derivation cohort, and 80.6% of the
alidation cohort, respectively.
In contrast to IMRcalc, IMRapp was significantly higher com-
ared with the true IMR (Fig. 3D). The correlation and agree-
ent between IMRapp and true IMR were also less strong
ompared with between IMRcalc and true IMR (Figs. 3E and 3F).
Subgroup analysis according to coronary artery distribution.
There were no significant differences between true IMR and
IMRcalc in both patients with left anterior descending artery
esions as well as patients with non-left anterior descending
rtery lesions (Online Fig. 1).
iscussion
A method to calculate the IMR in the presence of signifi-
Figure 1. Linear Regression of FFRcor Versus FFRmyo in the
Derivation Cohort
Solid line and formula shown were derived from the linear regression. The
r2 represents the ﬁt of the regression model, and p value reﬂects signiﬁ-
cance of the ﬁt. FFRcor  coronary fractional ﬂow reserve; FFRmyo  myo-
cardial fractional ﬂow reserve.cant epicardial stenosis without the need for Pw measure-
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56ment is demonstrated. The IMRcalc correlated and had good
agreement with the measured true IMR.
Measuring microcirculatory resistance. Recent studies sug-
gest that coronary microcirculatory impairment is an inde-
pendent predictor of poor prognosis in patients with mild or
Figure 2. Validation of Method to Calculate FFRcor
(A) Linear regression of measured coronary fractional ﬂow reserve (FFRco) vers
ues reﬂect signiﬁcance of the ﬁt. (B) Corresponding Bland-Altman plot. Dash
the bias.
Figure 3. Validation of Method to Calculate IMR
(A) Comparison between true index of microcirculatory resistance (IMR) and ca
error bars represent mean  SD. (B) Linear regression of true versus IMRcalc.
of the ﬁt. (C) Modiﬁed Bland-Altman plot showing the effect of myocardial fra
Dashed line denotes the bias of the agreement, and dotted lines represent S
ent index of microcirculatory resistance (IMRapp).no significant epicardial coronary disease (1–4). However,
there is a paucity of studies assessing coronary microcircu-
latory status in the presence of concurrent epicardial disease,
and the relative prognostic significance of coronary micro-
circulatory impairment in this setting is unknown. This is
culated FFRcor. The r
2 represents the ﬁt of the regression models, and p val-
e denotes the bias of the agreement and dotted lines represent SDs of
ed index of microcirculatory resistance (IMRcalc). Solid square boxes and
represents the ﬁt of the regression models, and p values reﬂect signiﬁcance
l ﬂow reserve (FFRmyo) on the difference between IMRcalc and true IMR.
the bias. (D to F) Corresponding comparison between true IMR and appar-us cal
ed linlculat
The r2
ctiona
Ds of
r
m
0
t
p
c
t
p
I
d
d
r
c
H
i
p
e
o
f
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 1 , 2 0 1 3 Yong et al.
J A N U A R Y 2 0 1 3 : 5 3 – 8 IMR Without Wedge Pressure Measurement
57likely because research in this area has been hampered by the
lack of a technique that independently interrogates the
microcirculation.
Techniques to evaluate the coronary microcirculation,
such as positron-emission tomography, nuclear perfusion
imaging, magnetic resonance imaging, echocardiographic
Doppler imaging, and invasive coronary flow reserve mea-
surements, by Doppler or thermodilution, are all based on
assessing absolute or relative microcirculatory blood flow
(2–4). Microcirculatory blood flow will be affected by
epicardial flow in the presence of significant epicardial
disease. Therefore, in the presence of significant epicardial
disease, all these techniques are unable to distinguish
between epicardial and microcirculatory impairment.
Invasive measurements of absolute or relative microcir-
culatory resistance with Doppler or thermodilution-based
techniques, including the IMR, are able to exclusively
evaluate the coronary microcirculation (7,21,22). However,
in the presence of significant epicardial stenosis, balloon
dilation is required for Pw measurement to account for
collateral flow in the calculation of microcirculatory resis-
tance (12–15). This has previously limited the measurement
of microcirculatory resistance in patients with significant
epicardial stenosis to those who are undergoing PCI
(5,14,15).
The development of FFR as a simple method to assess
the functional severity of epicardial stenosis severity has led
to its widespread use to aid revascularization strategy in the
cardiac catheterization laboratory (17,23). The method
presented in this study to measure microcirculatory resis-
tance in the presence of obstructive coronary disease, with-
out having to perform PCI, could potentially aid in the
clinical management of coronary microvascular issues, such
as post-infarction necrosis, myocardial recoverability, and
primary microvascular dysfunction.
Utility of the IMRapp in the presence of signiﬁcant epicardial
stenosis. The IMR is a quantitative measurement of min-
imum microcirculatory resistance (7) and is stable in re-
sponse to varying systemic hemodynamic conditions (20).
Previous studies that have measured IMR in the absence of
significant epicardial stenosis have shown that the IMR can
predict infarct size after ST-segment elevation myocardial
infarction (8,10,24), that the IMR after elective PCI can be
used to quantify size of periprocedural microcirculatory
disruption (9), and that the IMR can be used to determine
coronary microvascular status in heart transplant patients
(11). In addition, a previous study using Doppler-derived
microcirculatory resistance measured during balloon occlu-
sion in patients undergoing PCI showed that microcircula-
tory resistance was associated with periprocedural myocar-
dial necrosis (5).
In the absence of significant epicardial stenosis, as in
these studies, contribution of collateral flow to the target
microcirculation is insignificant. Therefore, the IMR wascalculated with the simplified formula for IMRapp in these
previous studies (8–11). The results of the current study are
consistent with previous published data in showing that it is
reasonable to calculate IMR with the formula for IMRapp
when FFR 0.80 and that the true IMR will be overesti-
mated by the IMRapp formula when FFR 0.80 (Fig. 3F)
(12,13).
Calculation of the IMR without Pw measurement. The cur-
ent study presents a novel, fairly simple mathematical
ethod to calculate the IMR without Pw. The IMRcalc,
derived by the formula: Pa  Tmn  ([1.35  Pd/Pa] 
.32), demonstrated good correlation and agreement with
he true IMR in the validation cohort.
The IMRcalc is less accurate when FFRmyo 0.45. A
ossible explanation is that Pd decreases as FFRmyo de-
reases. This causes an increase in the contribution of Pw
toward the equation to calculate FFRcor ([Pd  Pw]/[Pa 
Pw]) and results in greater discrepancy between estimated
FFRcor and measured FFRcor. From the regression line in
Figure 2, it is evident that this formula is also not valid when
FFRmyo is 0.24 when FFRcor becomes 0. Regardless of
hese issues, the IMRcalc was valid in most unselected
atients undergoing PCI where FFR 0.45.
Cohort heterogeneity. The significant variations in renal
function, lesion stenosis severity, and target vessel between
the derivation and validation cohorts likely reflect the differ-
ences in geography and practice among the different institu-
tions. That there was good agreement between IMRcalc and
true IMR despite these differences supports the validity of the
proposed method to calculate the IMR.
There were also several significant differences between the
institutions of the validation cohort. However, there were no
perceptible differences between the patients from these 2
institutions in validation of the IMRcalc (Figs. 3A to 3C).
There were also no significant differences between true
MR and IMRcalc in both patients with left anterior
escending artery lesions and patients with non-left anterior
escending artery lesions (Online Fig. 1). Microcirculatory
esistance might be affected by size of the distal microvas-
ulature and therefore could be dependent on lesion site.
owever, FFRcor and FFRmyo are both indexes that are
ndependent of distal territory size. Therefore, the current
roposed algorithm to calculate IMR on the basis of
stimation of FFRcor from FFRmyo should be independent
f lesion site, and the results shown are consistent with this
act.
Study limitations. First, IMR was only measured in 1 of the
major epicardial coronary arteries. Therefore, the results of
this study currently cannot be extrapolated to the left main
coronary artery or smaller branch vessels. Second, the
current method was only tested with the IMR. Although
the general principles described here should apply to other
methods, further studies will be required to validate the
application of the current algorithm to methods, such as the
l
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58absolute measurement of microcirculatory resistance with
thermodilution (21) or Doppler ultrasound (22). Last, this
study excluded patients with previous infarction in the
target territory, and caution has to be exercised when
extrapolating the results of this study to these patients.
There was, however, no observable difference between stable
and unstable angina patients in terms of the difference
between the IMRcalc and true IMR in the derivation cohort
(Online Fig. 2).
Conclusions
This study presents a method to assess the coronary micro-
vasculature in the presence of significant epicardial stenosis
without the need for balloon dilation for wedge pressure
measurement. Given the increasing awareness of the impor-
tance of the coronary microvasculature and the likely in-
creasing application of coronary physiological measure-
ments, we hope that the present method will facilitate future
studies involving assessment of the coronary microcircula-
tion in the cardiac catheterization laboratory.
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